A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2004
11/17/2004	EP1476434A2 Pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same
11/17/2004	EP1476431A1 Tricyclic pyrazole derivatives for the treatment of inflammation
11/17/2004	EP1476429A1 Novel pyridine- and quinoline-derivatives
11/17/2004	EP1476425A2 Heterocyclic arylsulfonamidobenzylic compounds
11/17/2004	EP1476423A2 Arylsulfonamidobenzylic compounds
11/17/2004	EP1476186A1 Use of an inhibitor or antagonist against tissue factor
11/17/2004	EP1476165A1 Substituted pyrimidinones and pyrimidinthiones
11/17/2004	EP1476159A2 Compositions and formulations of 9- nitrocamptothecin polymorphs and methods of use thereof
11/17/2004	EP1476158A1 Nicotinamide derivatives useful as pde4 inhibitors
11/17/2004	EP1476157A1 Nicotinamide derivatives useful as pde4 inhibitors
11/17/2004	EP1476156A2 Piperidine or pyrrolidine derivatives having an aminoacyl substituted side chain as melanocortin-4 receptor agonists
11/17/2004	EP1476143A1 Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies
11/17/2004	EP1476128A2 Lipase inhibiting composition
11/17/2004	EP1476032A1 Water dispersible coenzyme q10 dry powders
11/17/2004	EP1476018A1 Immunostimulant compositions comprising aminoalkyl glucosaminide phosphates and saponins
11/17/2004	EP1392713A4 Liver x receptor agonists
11/17/2004	EP1362045B1 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry
11/17/2004	EP1272468B1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands
11/17/2004	EP1185274B1 Drug combinations comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3a4
11/17/2004	EP1159457A4 T cell receptor vbeta beta-jbeta) sequence and methods for its detection
11/17/2004	EP1156999B1 Method for the preparation of a chiral-beta-amino ester
11/17/2004	EP1144409B1 Phenyl urea and phenyl thiourea derivatives
11/17/2004	EP1137667B1 Analogues of glp-1
11/17/2004	EP1109809B1 Pyrroloquinolines for treatment of obesity
11/17/2004	EP0943003B1 Insulin-like growth factor i (igf-i) expression system and methods of use
11/17/2004	EP0907658B1 Neuropeptide y agonists
11/17/2004	CN1547583A 多环鸟嘌呤磷酸二酯酶v抑制剂 Polycyclic guanine phosphodiesterase inhibitor v
11/17/2004	CN1547581A 二氮杂萘衍生物 Naphthyridine derivatives
11/17/2004	CN1547483A New use of ARTEMIN, a member of the GDNF ligand family
11/17/2004	CN1547482A Use of POLY-GLU,TYR and T cells treated therewith for neuroprotective therapy
11/17/2004	CN1547477A Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
11/17/2004	CN1547476A Use of ATAZANAVIR in HIV therapy
11/17/2004	CN1547473A Methods for preventing antipsychotic-induced weight gain
11/17/2004	CN1546533A Hericium erinaceus sulfate proteoglycan, preparation method thereof and pharmaceutical compositions with the same as active component
11/17/2004	CN1546491A Pteridine derivatives with nitric oxide synthase inhibitor function
11/17/2004	CN1546470A 6-phenylpyridyl-2-amine derivatives
11/17/2004	CN1546099A Preparation of Resina Draconis dispersing tablet
11/17/2004	CN1546097A Health tea capable of reducing blood lipid, blood viscosity and blood pressure
11/17/2004	CN1546080A Hyperlipemia treating medicine
11/17/2004	CN1546075A Fat-reducing medicine
11/17/2004	CN1546062A Animal used injection with calcium, phosphorus, magnesium or just calcium and phosphorus and preparing process thereof
11/17/2004	CN1546061A 维生素c钠胶囊 Vitamin c sodium capsules
11/17/2004	CN1546041A Ursolic acid dripping pills and its preparation process
11/17/2004	CN1546021A Oral liquid of sodium ozagrel and its application
11/17/2004	CN1546017A Compostion preparation of orlistat
11/17/2004	CN1546016A Nanometer preparation of natural vitamin E and its preparation
11/17/2004	CN1176092C Biphosphonate
11/17/2004	CN1176080C Indeno-, naphtho-, and benzocyclohepta-dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments
11/17/2004	CN1176072C Vitamin D3 analogs
11/17/2004	CN1175902C Sucked insulin preparation
11/17/2004	CN1175898C Medicine for treating complications of diabetes and its production process
11/17/2004	CN1175821C Composite vitamine and trace-element nutrient for gravida and puerpera
11/17/2004	CN1175818C Extractive preparation containing total alkali of mulberry leaves and its preparing method
11/17/2004	CN1175810C Composition containing calcium ascorbate and calcium L-threonate
11/17/2004	CN1175807C Disulfide derivatives useful for treating allergic diseases
11/16/2004	US6818767 Neuropeptide y (npy) antagonists for the treatment or prevention of arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders, or obesity
11/16/2004	US6818745 For diagnosis/treatment of tumors; drug screening of antitumor agents; metastatic-tumor excreted phosphaturic-element (mepe/phosphatonin)
11/16/2004	US6818658 Treating obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction.
11/16/2004	US6818655 2-aminoquinolines; cardiovascular, gastrointestinal, pyschological, respiratory and nervous system disorders
11/16/2004	US6818651 Antiinflammatory, antiasthmatic, skin, and autoimmune disorders; crohn*s disease, ulcerative colitis, conjuctivitis, multiple sclerosis, and rheumatoid arthritis; chronic obstructive pulmonary disease
11/16/2004	US6818646 1,2,3,4-tetrahydro-2-(5-(2-pyridinyl)-pyrimidin-2-yl)-3-(2,3 -dihydrobenzofuranyl)-9h-pyrrolo-(3,4-b)quinolin-9-one; male erectile dysfunction; sexual disorders
11/16/2004	US6818644 Fluorene-9-carboxylic amides; inhibitors of microsomal triglyseride-transfer protein (mtp); antilipemic agents; atherosclerosis, diabetes, eating disorders, and pancreatitis
11/16/2004	US6818638 Melvinolin derivatives
11/16/2004	US6818637 For use as antidiabetic agent
11/16/2004	US6818632 Protein tyrosine kinase and protein serin/threonine kinase inhibitory activity; anticancer agents; treating chemotherapy induced alopecia
11/16/2004	US6818619 Chimeric natriuretic peptides
11/16/2004	US6818445 Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
11/16/2004	US6818419 IRAK-4: compositions and methods of use
11/16/2004	US6818217 Immunoreactive peptides
11/11/2004	WO2004097047A1 Mutations in the human pcsk9 gene associated to hypercholesterolemia
11/11/2004	WO2004096853A1 Combined use of keratinocyte growth factor agonists and gastrin compounds
11/11/2004	WO2004096812A1 Fused pyrimidine derivative
11/11/2004	WO2004096811A1 Pde9 inhibitors for treating type 2 diabetes, metabokic syndrome, and cardiovascular disease
11/11/2004	WO2004096806A1 Fused imidazole derivative
11/11/2004	WO2004096801A1 Cannabinoid receptor ligands and uses thereof
11/11/2004	WO2004096797A1 Inhibitors of phosphatidylinositol 3-kinase
11/11/2004	WO2004096794A1 Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disordrs
11/11/2004	WO2004096788A1 Process fot the preparation of (4-hydroxy-6-oxo-tetrahydropyran-2-yl) acetonitrile and derivatives thereof
11/11/2004	WO2004096763A1 Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disorders
11/11/2004	WO2004096278A1 Adiponectin production enhancer
11/11/2004	WO2004096276A1 Sugar intake-ability enhancer
11/11/2004	WO2004096266A1 Improved physical stability of insulin formulations
11/11/2004	WO2004096211A1 Angiotensin ii receptor blockers for preventing the development or progression of microvascular disease due to diabetes
11/11/2004	WO2004096209A1 The use of azetidinecarboxamide derivatives in therapy
11/11/2004	WO2004096207A1 Body-temperature lowering depressant
11/11/2004	WO2004096205A1 A process for producing an additive comprising a salt obtained from hydroxy methionine and a trace element
11/11/2004	WO2004096202A1 Pharmaceutical formulation comprising anti-obesity agent and acidulant
11/11/2004	WO2004096201A1 Compositions for affecting weight loss
11/11/2004	WO2004096198A1 Therapeutic agent
11/11/2004	WO2004096172A2 Vector for oral administration
11/11/2004	WO2004085403B1 Tetrahydroisoquinolyl acetamide derivatives for use as orexin receptor antagonists
11/11/2004	WO2004083231A3 Use of peptide ligands for plasma membrane receptors or similar for mitochondrial activity modulation
11/11/2004	WO2004080482A3 Use of angiotensin converting enzyme (ace) inhibitors to prevent diabetes in a subject with chronic heart failure
11/11/2004	WO2004056745A3 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
11/11/2004	WO2004026907A3 Use of saccharomyces cerevisiae erg4 mutants for the expression of glucose transporters from mammals
11/11/2004	WO2003070747A3 Insulin and igf-1 receptor agonists and antagonists
11/11/2004	WO2003060150A8 Nucleic acids encoding a g-protein coupled receptor involved in islet cell signaling
11/11/2004	WO2003059264A9 Methods for the induction of professional and cytokine-producing regulatory cells
11/11/2004	WO2003050085A8 CRYSTALLINE [R-(R,R)]-2-(4-FLUOROPHENYL)-β,δ-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-HEPTANOIC ACID CALCIUM SALT (2:1)
11/11/2004	WO2003046574A3 Complement c3 precursor biopolymer markers indicative of insulin resistance

1 ... 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 ... 1298